2021-11-16-世界卫生组织-Cervical_cancer_Israel_2021_country_profile_1页_63kb

Israel Cervical Cancer Profile Summary

Morbidity and Mortality

• Crude and age-standardized cervical cancer incidence rates in 2020 were 5.6 and 4.9 per 100,000 women, respectively. The cumulative risk by age 74 was 0.5%, with 22,800 deaths in 2019. A population-based cancer registry exists (2021).

Primary Prevention

• HPV vaccination program is in place (2020), with 55% coverage among girls. HPV is included in the national vaccination program for 9-14-year-old girls, introduced in 2010. Age-specific coverage by 15 years is 52%. Risk factors include tobacco use (13% among 15+ year females, 2020) and HIV incidence data is not available.

Secondary Prevention

• National screening program exists (2021) using cytology, targeting ages 30-49 years. Ever screened rate is 67%, and a referral system is defined.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (2021). Treatment services, including radiotherapy and surgical facilities, are available, with high equipment numbers (e.g., 1182 radiotherapy units per 10,000 patients). Palliative care is accessible.

WHO Elimination Strategy

• Targets for 2030 focus on reducing incidence and mortality, leveraging prevention and screening programs.